- Combination Therapy by Tissue-Specific Suicide Gene and Bevacizumab in Intramedullary Spinal Cord Tumor
-
Gwak SJ, Che L, Yun Y, Lee M, Ha Y
- KMID: 2508969
- Yonsei Med J.
- 2020 Dec;61(12):1042-1049.
- doi: 10.3349/ymj.2020.61.12.1042
Purpose: Malignant gliomas are aggressive spinal cord tumors. In this study, we hypothesized that combination therapy using an anti-angiogenic agent, bevacizumab, and hypoxia-inducible glioblastoma-specific suicide gene could reduce tumor growth. Materials... -
- CITED
-
- Close
- SHARE
-
- Close
